ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Methylation of α-synuclein and leucine-rich repeat kinase 2 in leukocyte DNA of Parkinson's disease patients

Yu-yan Tan; Li Wu; Zong-bo Zhao; Ying Wang; Qin Xiao; Jun Liu; Gang Wang; Jian-fang Ma; Sheng-di Chen
PARKINSONISM & RELATED DISORDERS2014-3-1DOI: 10.1016/j.parkreldis.2013.12.002
11阅读
引用收藏
分享

摘要

Background<br/>Recent studies highlight the role of DNA methylation in the pathogenesis of Parkinson's disease (PD). However, there is a paucity of studies exploring the role of blood-based DNA methylation in PD. We aimed to explore identifiable epigenetic biomarkers for PD by analyzing the methylation status of α-synuclein (SNCA) and leucine-rich repeat kinase 2 (LRRK2) in leukocytes.<br/>Methods<br/>Bisulfite Specific PCR-based Sequencing method was used for semi-quantitative detection of methylation status of CpG islands in SNCA and LRRK2 promoter regions. Bisulfite Specific Cloning-based Sequencing method was used for further quantitative examination of CpG-2 methylation of SNCA. mRNA level was also detected in leukocytes.<br/>Results<br/>Semi-quantitative detection showed that the methylation status of SNCA CpG-2 differed between PD patients and normal controls, while there was no difference in CpG-1 of SNCA or in LRRK2 promoter. Further quantitative analysis by clonal assay showed that the CpG-2 of SNCA was hypomethylated in PD patients compared with the normal control (5.90% versus 7.69%, P?=?0.034). Moreover, among the 14 CpG sites of CpG-2, the 2nd, 4th and 9th CpG sites were significantly hypomethylated in PD patients. In subgroups of PD, the methylation level decreased in the early-onset PD patients (P?=?0.001). RT-PCR examination showed that SNCA mRNA was increased in PD patients compared with normal control (P?=?0.003).<br/>Conclusions<br/>Our results indicated that the methylation level of SNCA CpG-2, especially that of the 2nd, 4th and 9th CpG sites in leukocytes might have great potential to be a useful and informative biomarker in PD diagnosis and treatment.

学科与关键词

关键词
Parkinson&#x27s diseaseDNA methylationSNCALRRK2
相关
加载中…
  • α-synuclein A53T转基因帕金森小鼠模型DNA甲基化研究
    宋承远*博士, 中南大学, 2013-06-01.
  • DNA甲基化在帕金森病发病机制中的研究
    胡雅岑*博士, 中南大学, 2012.
  • Analysis of DNA methylation associates the cystine-glutamate antiporter SLC7A11 with risk of Parkinson's disease.
    Vallerga, Costanza L; Zhang, Futao; Fowdar, Javed; McRae, Allan F; Qi, Ting; Nabais, Marta F; Zhang, Qian; Kassam, Irfahan; Henders, Anjali K; Wallace, Leanne; Montgomery, Grant; Chuang, Yu-Hsuan; Horvath, Steve; Ritz, Beate; Halliday, Glenda; Hickie, Ian; Kwok, John B; Pearson, John; Pitcher, Toni; Kennedy, Martin; Bentley, Steven R; Silburn, Peter A; Yang, Jian; Wray, Naomi R; Lewis, Simon J G; Anderson, Tim; Dalrymple-Alford, John; Mellick, George D; Visscher, Peter M*Nature Communications, 2020, 11(1): 1238.
查看全部 →

发表信息

论文状态
公开发表
期刊
PARKINSONISM & RELATED DISORDERS
发表日期
2014-03-01
卷期
第 20 卷, 第 3 期
页码
308-313
DOI
10.1016/j.parkreldis.2013.12.002
语言
ENGLISH
期刊收录
SCIE
期刊等级
Q1
成果收录
SCIENCEDIRECT

作者

  • Y

    Yu-yan Tan (第一作者)

  • L

    Li Wu

查看全部 9 位作者收起作者
  • Z

    Zong-bo Zhao

  • Y

    Ying Wang

  • Q

    Qin Xiao

  • J

    Jun Liu

  • G

    Gang Wang

  • J

    Jian-fang Ma

  • S

    Sheng-di Chen

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417